Home » Authors » Holland Johnson

Articles by Holland Johnson

Deals roundup: BD to buy GeneOhm for $230M; Applera restructures Celera j-v

Jan. 11, 2006

By Holland Johnson

Boston Sci submits a definitive $25B offer to acquire Guidant

Jan. 10, 2006

By Holland Johnson

Angiotech's anti-microbial CVC trial pushes drug/device work

Jan. 9, 2006

By Holland Johnson

CAS is 2nd company to win U.S. cerebral oximeter okay

Jan. 5, 2006

By Holland Johnson

ReGen changes course, elects to pursue 510(k) for CMI device

Jan. 5, 2006

By Holland Johnson

Boston Sci makes a late play for Guidant with its $25B offer

Jan. 1, 2006

By Holland Johnson

Allergan’s $3.2B offer tops Medicis offer for Inamed

Jan. 1, 2006

By Holland Johnson

Boston Sci makes a late play for Guidant with $25B offer

Jan. 1, 2006

By Holland Johnson

Guidant takes a $4B cut to rescue merger

Dec. 1, 2005

By Holland Johnson

Innovation summit offers look at state of orthopedics sector

Dec. 1, 2005

By Holland Johnson

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...